The Newsroom

Investigations  /  02.18.2019

Shareholder Investigation of Nektar Therapeutics

Nektar Therapeutics (NKTR) Accused of Misrepresenting the Viability of its Drug NKTR-214 According to the ...

READ MORE
Investigations  /  02.15.2019

Shareholder Investigation of Venator

Venator Materials PLC (VNTR) Accused of Downplaying Impact of Devastating Fire at Its Facility According ...

READ MORE
Investigations  /  02.15.2019

Shareholder Investigation of Maiden Holdings

Maiden Holdings, Ltd. (MHLD) Accused of Subjecting Company to Risk of Financial Loss According to ...

READ MORE
Investigations  /  02.13.2019

Shareholder Investigation of Uxin Limited

Uxin Limited (UXIN) Accused of Inflating its IPO Price According to the complaint against the ...

READ MORE
Investigations  /  02.11.2019

Shareholder Investigation of Dentsply Sirona

Dentsply Sirona, Inc. (XRAY) Accused of Misrepresenting Its Financial Prospects in its Offering Documents According ...

READ MORE
Investigations  /  02.07.2019

SITO Mobile Survives Motion to Dismiss

Shareholder Class Action Alleging Defendants Made Materially False and Misleading Statements Survives Motion to Dismiss ...

READ MORE
Investigations  /  02.07.2019

TrueCar, Inc. Survives Motion to Dismiss

Shareholder Class Action Alleging TrueCar, Inc. (TRUE) Made Materially False and Misleading Statements Survives Motion ...

READ MORE
Investigations  /  02.05.2019

Shareholder investigation of Astec Industries

Astec Industries, Inc. (ASTE) Accused of Misrepresenting Capability of Its Wood Pellet Plants According to ...

READ MORE
Investigations  /  02.05.2019

Shareholder investigation of Synchrony Financial

Synchrony Financial (SYF) Accused of Misrepresenting Its Underwriting Practices According to the complaint against the ...

READ MORE
Investigations  /  02.04.2019

Shareholder investigation of Impinj, Inc.

Impinj, Inc. (PI) Accused of Misleading Investors Regarding Product Demand According to the complaint, on ...

READ MORE

How can we help you?

CONTACT US TODAY | 1-800-350-6003 or info@robbinsarroyo.com

Tell us your concerns